Xiaoyan Xie
- Genetics top 2%
- Mesenchymal stem cell research 13
- Virus-based gene therapy research 7
- Molecular Biology top 5%
- Pluripotent Stem Cells Research 24
- CRISPR and Genetic Engineering 11
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Biomaterials top 5%
- Surgery top 5%
- Tissue Engineering and Regenerative Medicine 9
-
- Erythrocyte Function and Pathophysiology 7
Xiaoyan Xie
96 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 118
- Genetics 499
- Molecular Biology 2.0k
- Cancer Research 345
- Biomaterials 231
- Surgery 768
Countries citing papers authored by Xiaoyan Xie
This map shows the geographic impact of Xiaoyan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Xie more than expected).
Fields of papers citing papers by Xiaoyan Xie
This network shows the impact of papers produced by Xiaoyan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Xie. The network helps show where Xiaoyan Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoyan Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 14 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 68 | |
| 10 | 2020 | 5 | |
| 11 | 2017 | 10 | |
| 12 | 2014 | 7 | |
| 13 | 2012 | 0 | |
| 14 | 2008 | 88 | |
| 15 | 2007 | 97 | |
| 16 | 2007 | 44 | |
| 17 | 2007 | 2 | |
| 18 | 2007 | 12 | |
| 19 | 2007 | 132 | |
| 20 | Establishment of Wnt3a--transfected bone marrow stromal cells and study on expansion of human umbilical cord blood CD34~(+) hematopoietic stem/progenitor cells {\sl in vitro} | 2005 | 1 |
About Xiaoyan Xie
Xiaoyan Xie is a scholar working on Genetics, Cancer Research and Hematology, having authored 103 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (24 papers), Mesenchymal stem cell research (13 papers), CRISPR and Genetic Engineering (11 papers), Tissue Engineering and Regenerative Medicine (9 papers), Erythrocyte Function and Pathophysiology (7 papers), Virus-based gene therapy research (7 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Genetics (499 citations), Molecular Biology (2.0k citations) and Cancer Research (345 citations). Xiaoyan Xie has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Joseph C. Wu, Feng Cao, Andrew J. Connolly, Robert C. Robbins, Zongjin Li, Sanjiv S. Gambhir, Irving L. Weissman, Shu-An Lin, Manishkumar Patel and Micha Drukker. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.